Predicting conversion surgery in patients with locally advanced pancreatic cancer after modified FOLFIRINOX treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predicting conversion surgery in patients with locally advanced pancreatic cancer after modified FOLFIRINOX treatment

Published:2023-09 Issue:9 Volume:46 Page:3542-3548
ISSN:1015-9584
Container-title:Asian Journal of Surgery
language:en
Short-container-title:Asian Journal of Surgery

Author:

Ninomiya Riki^ORCID,Abe Satoru,Chiyoda Takehiro^ORCID,Kogure Ryota,Kimura Akifumi,Komagome Masahiko,Maki Akira^ORCID,Beck Yoshifumi

Publisher

Elsevier BV

Subject

Surgery

Reference27 articles.

1. Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations;Huang;Gut,2019

2. Contemporary management of borderline resectable and locally advanced unresectable pancreatic cancer;Shaib;Oncol,2016

3. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011

4. Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial;Von Hoff;J Clin Oncol,2011

5. Neoadjuvant modified (m) FOLFIRINOX for locally advanced unresectable (LAPC) and borderline resectable (BRPC) adenocarcinoma of the pancreas;Blazer;Ann Surg Oncol,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP